Replies to post #157 on Avalon GloboCare Corp (ALBT)

[Quintessence]

"Avalon will hold a press conference to announce the launch of its exosome product commercialization plan, including a series of over-the-counter skincare and wound-healing products with Avalon's Clinical-grade Tissue-specific EXosomes as additives (ACTEX), on June 15, 2019 during the 2nd International Aesthetic Industry Conference in Chengdu, China -- the largest conference of its kind in Asia. In addition to product commercialization, this standardization of clinical-grade stem cell derived exosomes will lead to parallel development of Avalon's clinical programs, including AVA-202 and AVA-203, for angiogenic/orthopedic regeneration as well as treatment of fibrotic diseases."

https://finance.yahoo.com/news/avalon-globocare-announces-completion-clinical-120000239.html

[LivinLarge8]

$2.50 test and break coming